Literature DB >> 12426207

Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors.

Suya Yang1, Karen Toy, Gladys Ingle, Constance Zlot, P Mickey Williams, Germaine Fuh, Bing Li, Abraham de Vos, Mary E Gerritsen.   

Abstract

OBJECTIVE: This study evaluated the relative roles of the vascular endothelial growth factor (VEGF) receptors KDR and Flt-1 in the mediation of altered gene expression elicited by VEGF. METHODS AND
RESULTS: We used mutants of VEGF selective for the KDR and Flt-1 receptors to differentiate gene expression patterns mediated by wild-type VEGF (VEGFwt) in human umbilical vein endothelial cells. RNA was extracted from cells treated for 24 hours with 1 nmol/L of each ligand, and gene expression was monitored by using oligonucleotide arrays (Affymetrix U95A). We report that activation of KDR was sufficient to upregulate all the genes induced by VEGFwt. In contrast, there were no genes selectively upregulated by the Flt-selective mutant. However, high concentrations of the Flt-selective mutant could augment the expression of some genes induced by submaximal concentrations of VEGFwt but not the KDR-selective mutant.
CONCLUSIONS: The binding of VEGF to its receptor, KDR, is necessary and sufficient to induce the gene expression profile induced by this growth factor. Furthermore, in human umbilical vein endothelial cells, the Flt-1 receptor appears to act as a decoy receptor, tempering the response to lower concentrations of VEGF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426207     DOI: 10.1161/01.atv.0000038995.31179.24

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

1.  Neovascularization in the pulmonary endothelium is regulated by the endosome: Rab4-mediated trafficking and p18-dependent signaling.

Authors:  Havovi Chichger; Julie Braza; Huetran Duong; Myranda Stark; Elizabeth O Harrington
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-07       Impact factor: 5.464

2.  Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases.

Authors:  Fabricio Simão; Aline S Pagnussat; Ji Hae Seo; Deepti Navaratna; Wendy Leung; Josephine Lok; Shuzhen Guo; Christian Waeber; Christianne G Salbego; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-08       Impact factor: 6.200

Review 3.  A clinical-pathogenetic approach on associated anomalies and chromosomal defects supports novel candidate critical regions and genes for gastroschisis.

Authors:  Victor M Salinas-Torres; Rafael A Salinas-Torres; Ricardo M Cerda-Flores; Hugo L Gallardo-Blanco; Laura E Martínez-de-Villarreal
Journal:  Pediatr Surg Int       Date:  2018-08-09       Impact factor: 1.827

Review 4.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

5.  A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.

Authors:  David M Roberts; Amanda L Anderson; Michihiro Hidaka; Raymond L Swetenburg; Cam Patterson; William L Stanford; Victoria L Bautch
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  Statistical model to analyze quantitative proteomics data obtained by 18O/16O labeling and linear ion trap mass spectrometry: application to the study of vascular endothelial growth factor-induced angiogenesis in endothelial cells.

Authors:  Inmaculada Jorge; Pedro Navarro; Pablo Martínez-Acedo; Estefanía Núñez; Horacio Serrano; Arántzazu Alfranca; Juan Miguel Redondo; Jesús Vázquez
Journal:  Mol Cell Proteomics       Date:  2009-01-29       Impact factor: 5.911

7.  Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells.

Authors:  Nader Rahimi; Todd E Golde; Rosana D Meyer
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 8.  Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells.

Authors:  Mary E Gerritsen; James E Tomlinson; Constance Zlot; Michael Ziman; Stuart Hwang
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

9.  Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells.

Authors:  Malgorzata M Ptaszynska; Michael L Pendrak; Russell W Bandle; Mary L Stracke; David D Roberts
Journal:  Mol Cancer Res       Date:  2008-03       Impact factor: 5.852

10.  BU-32: a novel proteasome inhibitor for breast cancer.

Authors:  Joseph K Agyin; Bindu Santhamma; Hareesh B Nair; Sudipa S Roy; Rajeshwar R Tekmal
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.